Nations Financial Group Inc. IA ADV Has $387,000 Stock Position in SPDR S&P Biotech ETF $XBI

Nations Financial Group Inc. IA ADV lowered its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 86.8% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,860 shares of the exchange traded fund’s stock after selling 25,384 shares during the quarter. Nations Financial Group Inc. IA ADV’s holdings in SPDR S&P Biotech ETF were worth $387,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Ameriprise Financial Inc. lifted its position in shares of SPDR S&P Biotech ETF by 123.0% during the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after purchasing an additional 481,408 shares in the last quarter. Meitav Investment House Ltd. lifted its holdings in SPDR S&P Biotech ETF by 2,199.6% during the 2nd quarter. Meitav Investment House Ltd. now owns 400,454 shares of the exchange traded fund’s stock worth $33,229,000 after buying an additional 383,040 shares in the last quarter. JPMorgan Chase & Co. boosted its position in SPDR S&P Biotech ETF by 2.6% in the 2nd quarter. JPMorgan Chase & Co. now owns 10,638,105 shares of the exchange traded fund’s stock valued at $882,218,000 after buying an additional 268,399 shares during the last quarter. Marshall Wace LLP increased its stake in shares of SPDR S&P Biotech ETF by 102.3% in the 2nd quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock valued at $334,000 after buying an additional 179,029 shares during the period. Finally, Clal Insurance Enterprises Holdings Ltd increased its stake in shares of SPDR S&P Biotech ETF by 68.5% in the 2nd quarter. Clal Insurance Enterprises Holdings Ltd now owns 428,000 shares of the exchange traded fund’s stock valued at $35,494,000 after buying an additional 174,000 shares during the period.

SPDR S&P Biotech ETF Stock Down 0.1%

Shares of XBI opened at $124.18 on Tuesday. The stock’s fifty day simple moving average is $121.42 and its 200-day simple moving average is $104.80. The firm has a market capitalization of $8.22 billion, a PE ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 12-month low of $66.66 and a 12-month high of $129.12.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.